Maryland State Retirement & Pension System’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $645K | Buy |
5,670
+151
| +3% | +$17.2K | 0.01% | 810 |
|
2025
Q1 | $580K | Sell |
5,519
-844
| -13% | -$88.7K | 0.01% | 830 |
|
2024
Q4 | $682K | Buy |
6,363
+194
| +3% | +$20.8K | 0.01% | 864 |
|
2024
Q3 | $617K | Buy |
6,169
+263
| +4% | +$26.3K | 0.01% | 938 |
|
2024
Q2 | $498K | Hold |
5,906
| – | – | 0.01% | 1148 |
|
2024
Q1 | $469K | Sell |
5,906
-103
| -2% | -$8.18K | 0.01% | 1158 |
|
2023
Q4 | $429K | Hold |
6,009
| – | – | 0.01% | 1223 |
|
2023
Q3 | $360K | Sell |
6,009
-454
| -7% | -$27.2K | 0.01% | 1252 |
|
2023
Q2 | $466K | Hold |
6,463
| – | – | 0.01% | 1140 |
|
2023
Q1 | $475K | Sell |
6,463
-168
| -3% | -$12.4K | 0.01% | 1070 |
|
2022
Q4 | $443K | Buy |
+6,631
| New | +$443K | 0.01% | 1075 |
|
2022
Q3 | – | Sell |
-10,957
| Closed | -$610K | – | 806 |
|
2022
Q2 | $610K | Buy |
10,957
+214
| +2% | +$11.9K | 0.02% | 796 |
|
2022
Q1 | $754K | Buy |
10,743
+64
| +0.6% | +$4.49K | 0.02% | 769 |
|
2021
Q4 | $1.03M | Buy |
10,679
+160
| +2% | +$15.4K | 0.03% | 628 |
|
2021
Q3 | $922K | Buy |
+10,519
| New | +$922K | 0.03% | 665 |
|